91ÑÇÉ«´«Ã½

Journal News

From the journals: MCP

Naushin Raheema
By Naushin Raheema
July 5, 2024

Beyond microscopy: Mass spec's role in biopsies. Proteomic changes in learning and memory. Mapping mitochondria using mass spec. Read about papers on these topics recently published in the journal Molecular & Cellular Proteomics.

Beyond microscopy: Mass spec's role in biopsies

Microscopy is a standard method to assess biopsied tissue and look for abnormalities. This approach focuses largely on immunohistochemistry, or IHC, to identify and label cell lineage markers and therapeutic targets to provide insights for cancer diagnosis and treatment options. IHC has revolutionized cancer diagnosis and treatment, but it has faced significant obstacles in terms of standardization and consistency. While progress is being made to enhance IHC, its limited multiplexing capability and dependence on monospecific reagents may make it unsuitable for certain applications.

A recent  article in the journal Molecular & Cellular Proteomics by William Phipps and colleagues at the University of Washington and Fred Hutchinson Cancer Research Center discusses the challenges of using IHC for cancer diagnostics. It suggests that liquid chromatography–tandem mass spectrometry, or LC–MS/MS, might supplement biopsy testing methods. As laboratories use many different antibodies for IHC, antibody-based protein detection technologies may become less useful long-term; it may be hard to repeat results both within and between testing sites. Mass spectrometry could address conflicting results and supplement IHC.

The authors suggest that solutions using LC–MS/MS have several advantages, including increased specificity and sensitivity, decreased interference and turnaround time and the ability to multiplex. The authors stress that these methods would need to be appropriately calibrated, validated and consistently evaluated when used in the clinic.

Proteomic changes in learning and memory

Synaptic plasticity, the ability to change the strength of synapses, is important for learning and memory. An essential component of excitatory synapses is the postsynaptic density, or PSD, a dense network of hundreds of signaling molecules, neurotransmitter receptors and other proteins that control synaptic activity. Molecular and biological research has uncovered the identity and function of many of these proteins. However, researchers do not yet understand how the PSD changes during brain activities. Such insights could shed light on the neural networks that underlie memory and learning.

To address this gap in knowledge, Seok Heo and Taewook Kang of Johns Hopkins University and a group of researchers in Denmark examined the PSD proteome and phosphoproteome of mice after four different experiences, including inhibitory avoidance training, during which mice learn to associate the light or dark with an electrical shock. Their were published in the journal Molecular & Cellular Proteomics.

The authors showed that the PSD levels of kinases, phosphatases and their phosphorylation status changed upon inhibitory avoidance training. Furthermore, they found that Ppm1h, a phosphatase that inhibits neuron elongation, regulates synaptic plasticity in cell culture and animals. Future research will focus on further defining the role of Ppm1h to determine if it is involved in disorders of memory or learning.

Mapping mitochondria using mass spec

Mitochondria are essential organelles packed full of proteins that provide a cell’s energy. Numerous disorders are associated with mitochondrial enzyme or protein complex malfunction, including mitochondrial encephalopathy and Leber hereditary optic neuropathy. Many of these proteins reside in separate subcompartments and physically interact with one another. This huge diversity of interactions makes it difficult to fully catalogue mitochondrial interactome.

Johannes F. Hevler and Albert J.R. Heck of the University of Utrecht recently published a in the journal Molecular & Cellular Proteomics discussing the current state of crosslinking mass spectrometry, or XL-MS,  and highlighting how it can be used to study the mitochondrial interactome Recent developments, such as cryogenic electron tomography, have further elucidated the mitochondria’s intricate membrane mazes. The authors assert that understanding these structures can be strengthened by XL-MS data, which uses distant restraints to reveal contact sites in protein­–protein interactions. Other methods, such as affinity purification-mass spectrometry and identification by biotin ligation can further validate the interactions but are performed under less natural conditions.

The authors also discuss limitations of XL-MS, including low reaction efficiency, meaning that researchers cannot detect all protein interactions yet, especially that rare protein interactions may be missed. However, the authors argue that XL-MS is an ideal tool for discovering the mitochondrial interactome, despite these disadvantages.

Enjoy reading 91ÑÇÉ«´«Ã½ Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Naushin Raheema
Naushin Raheema

Naushin Raheema is a science communicator and writer. She writes articles on health, space, genetics and the environment. She writes poems and does art journaling in her free time.
 

Get the latest from 91ÑÇÉ«´«Ã½ Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Melissa Moore to speak at 91ÑÇÉ«´«Ã½ 2025
91ÑÇÉ«´«Ã½ Annual Meeting

Melissa Moore to speak at 91ÑÇÉ«´«Ã½ 2025

April 2, 2025

Richard Silverman and Melissa Moore are the featured speakers at the 91ÑÇÉ«´«Ã½ annual meeting to be held April 12-15 in Chicago.

 A new kind of stem cell is revolutionizing regenerative medicine
Feature

A new kind of stem cell is revolutionizing regenerative medicine

April 1, 2025

Induced pluripotent stem cells are paving the way for personalized treatments to diabetes, vision loss and more. However, scientists still face hurdles such as strict regulations, scalability, cell longevity and immune rejection.

Engineering the future with synthetic biology
91ÑÇÉ«´«Ã½ Annual Meeting

Engineering the future with synthetic biology

March 31, 2025

Learn about the 91ÑÇÉ«´«Ã½ 2025 symposium on synthetic biology, featuring applications to better human and environmental health.

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance
Webinar

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance

March 28, 2025

Alejandro Vila, an 91ÑÇÉ«´«Ã½ Breakthroughs speaker, discussed his work on metallo-β-lactamase enzymes and their dependence on zinc.

Host vs. pathogen and the molecular arms race
91ÑÇÉ«´«Ã½ Annual Meeting

Host vs. pathogen and the molecular arms race

March 28, 2025

Learn about the 91ÑÇÉ«´«Ã½ 2025 symposium on host–pathogen interactions, to be held Sunday, April 13 at 1:50 p.m.

Richard Silverman to speak at 91ÑÇÉ«´«Ã½ 2025
91ÑÇÉ«´«Ã½ Annual Meeting

Richard Silverman to speak at 91ÑÇÉ«´«Ã½ 2025

March 27, 2025

Richard Silverman and Melissa Moore are the featured speakers at the 91ÑÇÉ«´«Ã½ annual meeting to be held April 12-15 in Chicago.